Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nordmark Biochemicals is a specialized division of Nordmark Pharma GmbH, a German pharmaceutical company based in Uetersen. The company is a global leader in the production of high-quality enzymes, particularly Collagenase and Neutral Protease, used for tissue dissociation and cell isolation in research and clinical applications. Their flagship product line, Collagenase NB, is widely utilized in regenerative medicine, including islet cell transplantation for the treatment of Type 1 diabetes. Nordmark operates under strict GMP standards, providing both research-grade and clinical-grade enzymes to the global biotech and medical communities. Additionally, the company offers CDMO services for the development and manufacturing of biological active ingredients derived from animal tissues or produced via fermentation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nordmark Biochemicals.